Robert Clifton Yates serves as Executive at Ortho Clinical Diagnostics Holdings plc, where they oversee executive responsibilities. Since joining the company, Robert Clifton Yates has executed 10 insider transactions totaling $7.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on May 27, 2022 involved selling 323,880 shares valued at $0.
Robert Clifton Yates currently holds 4,218 shares of Ortho Clinical Diagnostics Holdings plc (OCDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Clifton Yates has been a net seller of OCDX stock. They have purchased $0 and sold $7.4M worth of shares.
Robert Clifton Yates's most recent insider trade was on May 27, 2022, when they sold 323,880 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $18.66 |
| Discretionary |
| Jan 3, 2022 | OCDX | $4.5K | Payment | 214 | $21.12 | Discretionary |
| Sep 30, 2021 | OCDX | $5.1K | Payment | 277 | $18.48 | Discretionary |
| Aug 5, 2021 | OCDX | $5.7K | Payment | 277 | $20.69 | Discretionary |
| Aug 4, 2021 | OCDX | $3.1M | Sale | 140,042 | $21.79 | Discretionary |
| Aug 3, 2021 | OCDX | $3.8M | Sale | 176,149 | $21.59 | Discretionary |
| Aug 2, 2021 | OCDX | $144.8K | Option Exercise | 23,062 | $6.28 | Discretionary |
| Aug 2, 2021 | OCDX | $563.7K | Sale | 25,551 | $22.06 | Discretionary |
| May 3, 2021 | OCDX | $0 | Award | 5,200 | $N/A | Discretionary |